⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AIDX News
20/20 Biolabs, Inc. Common Stock
HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research Ready to Announce with Confidence?
newsfilecorp.com
AIDX
Form 8-K
sec.gov
AIDX
Form 8-K
sec.gov
AIDX
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
globenewswire.com
AIDX
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
globenewswire.com
AIDX
Form 8-K
sec.gov
AIDX
Form 8-K
sec.gov
AIDX
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
globenewswire.com
AIDX
Form 8-K
sec.gov
AIDX
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
globenewswire.com
AIDX